Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Lonidamine

Lonidamine

pharmaceutical raw materials
Lonidamine structure

Lonidamine 

structure
  • CAS No:

    50264-69-2

  • Formula:

    C15H10Cl2N2O2

  • Chemical Name:

    Lonidamine

  • Synonyms:

    1H-Indazole-3-carboxylic acid,1-[(2,4-dichlorophenyl)methyl]-;1-[(2,4-Dichlorophenyl)methyl]-1H-indazole-3-carboxylic acid;1-(2,4-Dichlorobenzyl)-1H-indazole-3-carboxylic acid;Diclondazolic acid;DICA;AF 1890;Lonidamine;1-[(2,4-Dichlorophenyl)methyl]indazole-3-carboxylic acid;57571-43-4

  • Categories:

    Active Pharmaceutical Ingredients  >  Antineoplastic Agents

Description

Lonidamine is an orally administered small molecule hexokinase inactivator.Target: OthersLonidamine is a derivative of indazole-3-carboxylic acid, which for a long time, has been known to inhibit aerobic glycolysis in cancer cells. It seems to enhance aerobic glycolysis in normal cells, but suppress glycolysis in cancer cells. This is most likely through the inhibition of the mitochondrially bound hexokinase. Later studies in Ehrlich ascites tumor cells showed that lonidamine inhibits bo


Lonidamine is a member of the class of indazoles that is 1H-indazole that is substituted at positions 1 and 3 by 2,4-dichlorobenzyl and carboxy groups, respectively. It has a role as an antispermatogenic agent, an antineoplastic agent, a geroprotector and an EC 2.7.1.1 (hexokinase) inhibitor. It is a member of indazoles, a dichlorobenzene and a monocarboxylic acid.|Lonidamine (LND) is a drug that interferes with energy metabolism of cancer cells, principally inhibiting aerobic glycolytic activity, by its effect on mitochondrially-bound hexokinase (HK). In such way LND could impair energy-requiring processes, as recovery from potentially lethal damage, induced by radiation treatment and by some cytotoxic drugs.|Lonidamine is an indazole carboxylic acid derivative that exhibits radiosensitizing and antiparasitic effects and interferes with the multidrug resistance mechanism.

Lonidamine Basic Attributes

321.16

321.16

256-510-0

U78804BIDR

758419|741419

DTXSID5020782

C1146

L - Antineoplastic and immunomodulating agents

2933990090

Characteristics

55.1

4.3

white to light yellow crystal

1.49 g/cm3

207 °C

537.9°C at 760 mmHg

279.1±28.7 °C

1.678

Store at RT

LD50 in mice, rats (mg/kg): 900, 1700 orally; 435, 525 i.p. (Heywood)

Safety Information

NONH for all modes of transport

3

60-22-40

53-22-36/37/39-45

NK7886000

T

P201-P281-P308 + P313

H302-H351-H360

|Danger|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P264, P270, P281, P301+P312, P308+P313, P330, P405, and P501|Aggregated GHS information provided by 40 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Investigated for use/treatment in benign prostatic hyperplasia, prostate disorders, and cancer/tumors (unspecified).

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)|Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. (See all compounds classified as Trypanocidal Agents.)|Agents, either mechanical or chemical, which destroy spermatozoa in the male genitalia and block spermatogenesis. (See all compounds classified as Antispermatogenic Agents.)|Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)

Lonidamine has known human metabolites that include (2S,3S,4S,5R)-6-[1-[(2,4-Dichlorophenyl)methyl]indazole-3-carbonyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid.

Lonidamine is an orally administered small molecule that inhibits glycolysis by the inactivation of hexokinase. Hexokinase is an enzyme that catalyzes glucose, the first step in glycolysis. The inhibition of hexokinase by lonidamine is well established. In addition, there is evidence that lonidamine may increase programmed cell death. This stems from the observation that mitochondria and mitochondria-bound hexokinase are crucial for induction of apoptosis; agents that directly effect mitochondria may, therefore, trigger apoptosis. Indeed, in vitro models with lonidamine exhibit the hallmarks of apoptosis, including mitochondrial membrane depolarization, release of cytochrome C, phosphatidylserine externalization, and DNA fragmentation. [PMID: 16986057]

1-(2,4-dichlorobenzyl)indazole-3-carboxylic acid

Lonidamine Use and Manufacturing

Methods of Manufacturing

Indoloquinone is added to an aqueous solution of sodium hydroxide to hydrolyze the ring to obtain compound (I). The compound (I) was mixed with an aqueous solution of sodium nitrite at 0°C, and the mixed solution was dropped into an aqueous solution of sulfuric acid, kept at 4°C or less, and continued to be stirred to obtain a diazonium salt solution. At 0°C with stirring, a concentrated solution of stannous chloride in hydrochloric acid was added dropwise, and stirring was continued. After filtration, a yellow-brown solid was obtained, and glacial acetic acid was recrystallized to obtain yellow needle-like crystals of indazole-3-carboxylic acid (III) in a yield of 51.2%. The indazole carboxylic acid, sodium hydroxide, water and potassium iodide are added together, under the protection of nitrogen, at 100° C. with stirring, 2, 4-dichlorobenzyl chloride is slowly added dropwise, and the reaction is continued after the addition. The crystals were collected by filtration and recrystallized with ethanol to obtain lonidamine, with a yield of 87.5% and a melting point of 205-206°C. The final reaction can also be carried out as follows: 1H-indino-3-carboxylic acid is dissolved in a solution of 8g sodium hydroxide and 160ml of water, and 2, 4-dichlorobenzyl chloride is added under heating and stirring in a water bath. Continue to heat for 3h, cool, and adjust to acidity with dilute hydrochloric acid. The precipitated crude clonidine is recrystallized with acetic acid, yield. 70%, melting point 207℃.

Uses

contraceptive, spermicidal

Computed Properties

Molecular Weight:321.2
XLogP3:4.3
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:3
Exact Mass:320.0119330
Monoisotopic Mass:320.0119330
Topological Polar Surface Area:55.1
Heavy Atom Count:21
Complexity:396
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Lonidamine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.